Now accepting Telehealth appointments. Schedule a virtual visit.

January CHR VOICE Digest

January CHR VOICE Digest

The VOICE is getting an upgrade! Based on feedback from our readers, each month we will be highlighting what we consider the most important news for fertility patients and professionals working in the field. Do you have a topic you would love covered in next month's VOICE? We would love to hear your feedback by emailing ldellere@thechr.com

In this months CHR VOICE, we cover:

Finally, a surrogacy law in New York State

For some time NY state has been one of only three states without laws allowing surrogacy. As of February 15, 2021, the state will join the majority, facilitating legal arrangement of paid surrogacy in New York state and conducting clinical surrogacy in the state within an existing framework that defines the woman who hired the gestational carrier as the birth mother. Read more about the new law here.

A new clinical trial at CHR for women who need growth hormone

Human growth hormone (HGH) has over the last decade returned to popularity in IVF cycles and is increasingly utilized at many IVF centers, including at CHR. The costs of HGH for patients are, however, significant. To potentially save patients thousands of dollars, CHR is announcing a preliminary trial of a drug called Semorelin, which releases endogenous HGH from the pituitary. Read more about how to qualify for the study here.

First class–action lawsuit because of PGT-A

One could argue that a class-action lawsuit regarding preimplantation genetic testing for aneuploidy (PGT-A) had to happen sooner or later. According to press reports, plaintiffs’ claims are that the two IVF centers may have incorrectly classified potentially healthy embryos as abnormal and, therefore, mistakenly discarded healthy embryos, thereby robbing patients of their chances of having children. Read more about the lawsuit here.

Also included in the January VOICE:

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

 


We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS

 

You Might Also Enjoy...

The Voice October 2021

We welcome our readers to the October issue of the VOICE, we hope again packed with interesting and relevant information for patients, colleagues, and any other party interested in reproductive sciences and clinical infertility. October is ...

The Voice September 2021

We are pleased to welcome you to the first issue of the VOICE for the academic year 2021/2022. A new publishing team has taken over, and differences in style and content distribution will, therefore, become quickly apparent. Hopefully also very apparent...

Telehealth: The Advantages of Telemedicine

Struggles to get to the clinic? Trying to reduce your exposure to COVID-19, as well as other contagious illnesses, and still need to see your doctor? Telehealth is safe and easy — receive quality care from anywhere.

The latest news in Science: May 2021

In this section we attempt to draw attention to science papers we perceive as potentially important for the basic understanding of reproductive biology and, therefore, may have translational relevance to ...